Hillerod, Denmark

Bo Kreilgard


Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 36(Granted Patents)


Location History:

  • Hilleröd, DK (2003)
  • Hillerod, DK (2003 - 2006)

Company Filing History:


Years Active: 2003-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Bo Kreilgard: Innovator in Transdermal Drug Delivery

Introduction

Bo Kreilgard is a notable inventor based in Hillerod, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of transdermal drug delivery systems. With a total of 3 patents to his name, Kreilgard's work focuses on innovative formulations aimed at treating various medical conditions.

Latest Patents

Kreilgard's latest patents include groundbreaking inventions such as "Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder." This invention involves a set of formulations containing tolterodine and its derivatives, designed for transdermal administration alongside other methods to effectively treat overactive bladder symptoms. Another significant patent is "Transdermally administered acetylcysteine as mucolytic agent," which details a device for the transdermal delivery of N-Acetyl-L-cysteine. This invention aims to achieve a mucolytic effect, providing therapeutic benefits to both humans and animals.

Career Highlights

Throughout his career, Bo Kreilgard has worked with prominent companies in the pharmaceutical industry, including Pharmacia AB and Pfizer Health AB. His experience in these organizations has contributed to his expertise in drug formulation and delivery systems.

Collaborations

Kreilgard has collaborated with several professionals in his field, including Ulla Hoeck and Lene Orup Jacobsen. These partnerships have likely enhanced his research and development efforts, leading to innovative solutions in drug delivery.

Conclusion

Bo Kreilgard's contributions to transdermal drug delivery systems highlight his role as an influential inventor in the pharmaceutical industry. His patents reflect a commitment to improving treatment options for patients with various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…